Bio-Gene Technology Ltd

NEW
ASX:BGT (Australia)   Ordinary Shares
A$ 0.017 (0%) Jul 10
At Loss
P/B:
4.25
Market Cap:
A$ 6.56M ($ 4.56M)
Enterprise V:
A$ 5.38M ($ 3.74M)
Volume:
59.57K
Avg Vol (2M):
685.83K
Trade In:
Volume:
59.57K
At Loss
Avg Vol (2M):
685.83K

Bio-Gene Technology Ltd (ASX:BGT) Dividend

Bio-Gene Technology Ltd (ASX:BGT) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -20.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:BGT Dividend

Does Bio-Gene Technology Ltd (ASX:BGT) pay a dividend?

Bio-Gene Technology Ltd (ASX:BGT) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Bio-Gene Technology Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Bio-Gene Technology Ltd has returned capital to shareholders via buybacks at a rate of -20.2% over the past 3 years.

What are dividend-paying alternatives to Bio-Gene Technology Ltd?

For dividend-paying alternatives in Bio-Gene Technology Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.